Biotech Stocks Technical Insight -- ARIAD Pharma, Geron, PDL BioPharma, Cytori Therapeutics, and Navidea Biopharma
PR Newswire - Thu Dec 18, 8:15AM CST
Investor-Edge has initiated coverage on the following equities: ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA), Geron Corporation (NASDAQ: GERN), PDL BioPharma Inc. (NASDAQ: PDLI), Cytori Therapeutics Inc. (NASDAQ: CYTX), and Navidea Biopharmaceuticals Inc. (NYSE MKT: NAVB). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Wednesday, December 17, 2014, surged as the Dow Jones Industrial Average finished at 17,356.87, up 1.69% and the NASDAQ Composite closed at 4,644.31, up 2.12%. The S&P 500 finished the session 2.04% higher at 2,012.89. During the trading session, all the ten sectors finished on a higher note. The S&P 500 Health Care Index ended the day at 791.66, up 1.90%, with the index advancing 6.28% in the previous three months. Register for your complimentary reports on these five stocks at:
NAVB: 2.00 (+0.02), CYTX: 0.48 (-0.01), GERN: 3.06 (+0.05), ARIA: 6.81 (+0.15), PDLI: 7.61 (unch)
PDL BioPharma declares $0.15 dividend
Seeking Alpha - at Seeking Alpha - Mon Dec 15, 3:10PM CST
PDLI: 7.61 (unch)
PDL BioPharma's Q4 Revenues to Rise Y/Y on Higher Royalties - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 3:10PM CST
PDL BioPharma (PDLI) estimates revenues to increase 41% from the year-ago period to roughly $158 million in the fourth quarter of 2014.
BIIB: 340.89 (+5.13), NVS: 93.91 (+0.66), PDLI: 7.61 (unch)
PDL BioPharma Provides Fourth Quarter 2014 Revenue Guidance of $158 Million
PR Newswire - Wed Dec 10, 3:02PM CST
PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced revenue guidance for the fourth quarter ending December 31, 2014, of approximately $158 million, as compared with actual revenue of $112 million for the fourth quarter of 2013, an approximate 41 percent increase.
PDLI: 7.61 (unch)
Is It Time to Buy This Growth Stock?
George Budwell, The Motley Fool - Motley Fool - Mon Dec 08, 8:43AM CST
Pharmaceutical stocks have absolutely soared amid the broader bull market. Shares of the specialist and generic drugmaker Actavis plc , for example, have more than tripled in value since 2012 alone: Actavis' rocket-like trajectory, though,...
AGN: 210.12 (+0.95), VRX: 140.33 (-0.22), ACT: 254.20 (-1.68), CBST: 100.29 (-0.09), PFE: 31.42 (-0.03), PDLI: 7.61 (unch)
Danger Lurks in These 3 High-Yield Dividend Stocks
Motley Fool Staff - Motley Fool - Sun Dec 07, 9:09AM CST
Source: Flickr user Shawn Carpenter . The allure of high-dividend yields is endlessly enticing, but often, high-dividend stocks come with higher-than-anticipated risks. In a bid to help identify high-dividend-paying companies that may stumble, we...
PETS: 14.23 (+0.08), GSK: 42.85 (+0.11), PDLI: 7.61 (unch)
PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes
PR Newswire - Thu Dec 04, 3:01PM CST
PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the adjusted conversion rate for the:
PDLI: 7.61 (unch)
Dividend Dogs Of Healthcare: A 29.17% Advantage For The 5 Lowest Price High Yield Stocks
Fredrik Arnold - at Seeking Alpha - Thu Dec 04, 8:37AM CST
SNN: 38.18 (+0.14), VIVO: 16.68 (-0.02), PETS: 14.23 (+0.08), PFE: 31.42 (-0.03), MRK: 57.46 (+0.25), AZN: 70.44 (+0.26), THRX: 14.55 (+0.22), GSK: 42.85 (+0.11), SNY: 46.35 (+0.50), PDLI: 7.61 (unch)
5 Prime Dividend Dogs Of Healthcare Hound 11% To 45.4% November Upsides
Fredrik Arnold - at Seeking Alpha - Thu Dec 04, 2:40AM CST
KND: 18.21 (+0.11), VIVO: 16.68 (-0.02), PETS: 14.23 (+0.08), PFE: 31.42 (-0.03), GSK: 42.85 (+0.11), MSA: 53.48 (+0.79), HLS: 40.45 (+0.12), SEM: 14.67 (+0.27), PDLI: 7.61 (unch), SNN: 38.18 (+0.14), AZN: 70.44 (+0.26), MRK: 57.46 (+0.25), TRIB: 16.98 (-0.13), TEVA: 57.09 (+0.33), THRX: 14.55 (+0.22), SNY: 46.35 (+0.50)
Direct Flow Medical(R) Announces New Financing of $32 Million
Business Wire - Wed Dec 03, 7:01AM CST
Direct Flow Medical(R), Inc., a transcatheter heart valve innovator focused on improving patient outcomes, announced the closing of a new round of financing for the company totaling $32 million. Simultaneously, the company announced the appointment of Chris Richardson as its first Chief Commercial Officer to support global growth of the Direct Flow Medical Transcatheter Aortic Valve System.
PDLI: 7.61 (unch)
Insider Trading Alert - SPB, RH And PDLI Traded By Insiders
at The Street - Mon Dec 01, 9:30AM CST
Stocks with insider trader activity include SPB, RH and PDLI
RH: 96.97 (-0.16), SPB: 97.15 (-0.49), PDLI: 7.61 (unch)
3 Dangerous Dividend Stocks
Motley Fool Staff - Motley Fool - Mon Dec 01, 8:16AM CST
Yield. Danger ahead. You won't just see these warnings while on the road this holiday season -- they also relate to some dividend stocks. Investors can be enticed by high dividend yields, but sometimes the stocks themselves are dangerous picks. We...
FTR: 6.76 (-0.02), PSEC: 8.59 (-0.02), PDLI: 7.61 (unch)
InsiderInsights.com Daily Round Up 11/28/14: BBY, XOM, NES, FRAF
InsiderInsights - at Seeking Alpha - Sun Nov 30, 2:02AM CST
SIRO: 88.95 (+0.31), RH: 96.97 (-0.16), LPSB: 12.07 (-0.18), NES: 4.96 (-0.44), COTY: 20.67 (+0.40), XOM: 93.78 (-0.81), BBY: 38.89 (-0.80), SPB: 97.15 (-0.49), LIOX: 5.82 (+0.05), RM: 16.02 (+0.37), NEWM: 24.15 (+0.54), PDLI: 7.61 (unch), PDM: 19.03 (+0.01), PLUS: 72.63 (+0.09), WD: 17.63 (+0.28), HRG: 13.98 (-0.02), NMBL: 29.03 (+0.06)
3 Companies That Could Slash Their Dividends
Motley Fool Staff - Motley Fool - Mon Nov 24, 11:30AM CST
As investors, we like to see companies with strong dividends that increase over time. However, on occasion, companies are forced to cut their dividend due to a lack of cash flow, too high of a payout ratio, or even because of government regulators in...
FSC: 8.08 (+0.01), PFE: 31.42 (-0.03), FSAM: 13.35 (-0.07), PDLI: 7.61 (unch)
PDL BioPharma Earnings Review: 14 Days after Announcement Shares Down 0.9% (PDLI)
Comtex SmarTrend(R) - Mon Nov 24, 8:56AM CST
14 days ago, on November 10th, 2014, PDL BioPharma (NASDAQ
PDLI: 7.61 (unch)
This High-Yield Dividend Stock Screams Danger
Sean Williams, The Motley Fool - Motley Fool - Fri Nov 21, 7:45AM CST
Source: Flickr user Sunshinecity When it comes to crafting the perfect retirement portfolio, I'd be remiss if I played down the critical role that dividends have in supplementing retirees' incomes and providing compounding gains over time for...
BIIB: 340.89 (+5.13), PDLI: 7.61 (unch)
PDL BioPharma Announces Successful Conclusion of Debt Financing Agreement with Durata Therapeutics
PR Newswire - Tue Nov 18, 6:00AM CST
PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that in connection with the acquisition of Durata Therapeutics, Inc. by Actavis, PDL has received approximately $42.7 million in connection with the termination of PDL's credit agreement with Durata, which included repayment of the full principal amount outstanding of $40 million, accrued interest, and prepayment and change of control premiums. In October 2013, PDL entered into a structured financing transaction with Durata in which PDL agreed to provide Durata with up to $70 million of debt financing with a five year term and in turn would receive interest on the principal amount outstanding and a security interest in substantially all of Durata's assets.
DRTX: 24.16 (+0.41), PDLI: 7.61 (unch)
PDL BioPharma Earnings In Retrospect: Down 1.8% in the Last 7 Days (PDLI)
Comtex SmarTrend(R) - Mon Nov 17, 1:06PM CST
A week ago on November 10th, 2014 PDL BioPharma (NASDAQ
PDLI: 7.61 (unch)
Buy-Rated Dividend Stocks In The Top 3: RGP, PDLI, SUI
at The Street - Mon Nov 17, 9:30AM CST
These 3 dividend stocks are rated a Buy by TheStreet
SUI: 62.18 (-0.08), RGP: 23.76 (+0.01), PDLI: 7.61 (unch)
PDL BIOPHARMA 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against PDL BioPharma, Inc. -- PDLI
GlobeNewswire - Fri Nov 14, 9:00PM CST
Kahn Swick & Foti, LLC ("KSF"
PDLI: 7.61 (unch)